Pregnancy in a patient with mitochondrial disease;Grossesse chez une patiente atteinte de cytopathie mitochondriale

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 33, Issue 2, 2004, Pages 131-139

  Racine, A C ^a   Blanchot, G ^b   Le Vaillant, C ^a   Boog, G ^a  

^a Hopital Mere Enfant CHU de Nantes   (France)

^b HÔTEL DIEU   (France)

Author keywords

Pregnancy and mitochondrial disease; Respiratory chain disorders

Indexed keywords

ATENOLOL; CARNITINE; CLONIDINE; ENOXAPARIN; FUROSEMIDE; GABAPENTIN; LABETALOL; NEUTRAL INSULIN; NICARDIPINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; KIDNEY PROXIMAL TUBULE; KIDNEY TRANSPLANTATION; LEUKOENCEPHALOPATHY; MITOCHONDRIAL RESPIRATION; MUSCLE BIOPSY; MUSCLE WEAKNESS; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR;

EID: 1842450806     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0368-2315(04)96412-5     Document Type: Article

References (50)

1. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. Conversion de l'énergie: mitochondries et chloroplastes. In: Biologie moléculaire de la cellule. Deuxième édition. Flammarion, Paris, 1990; 341-404.
2. Leonard JV, Schapira AH. Mitochondrial respiratory chain disorders. I: mitochondrial DNA defects. Lancet 2000; 355: 299-304.
3. Leonard JV, Schapira AH. Mitochondrial respiratory chain disorders. II: neurodegenerative disorders and nuclear gene defects Lancet 2000; 355: 389-94.
4. Pandolfo M, Montermini L. Prenatal diagnosis of Friedreich ataxia. Prenat Diagn 1998; 18: 831-3.
5. Blanche S, Tardieu M, Rustin P, Slama A, Barret B, Firtion G, et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 1999; 354: 1084-9.
6. Poulton J, Lyall H, Taylor G, Williams GT. HIV-1 therapy and fetal mitochondrial dysfunction. Lancet 1999; 354: 2081-2.
7. The Perinatal Safety Review Working Group. Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts. J Acquir Immune Defic Syndr 2000; 25: 261-8.
8. Gillis L, Kaye E. Diagnosis and management of mitochondrial diseases. Pediatr Clin North Am 2002; 49: 203-19.
9. Munnich A, Rustin P. Clinical spectrum and diagnosis of mitochondrial disorders. Am J Med Genet 2001; 106: 4-17.
10. Rötig A. Cytopathies mitochondriales: diagnostic postnatal et diagnostic prénatal. Med fœt Echogr Gynecol 2002; 50: 19-24.
11. Dreval D, Bernstein D, Zakut H. Carnitine palmitoyl transferase deficiency in pregnancy- a case report. Am J Obstet Gynecol 1994; 170: 1390-2.
12. Blake LL, Shaw R.W. Mitochondrial myopathy in a primigravid pregnancy. Br J Obstet Gynaecol 1999; 106: 871-3.
13. Ewart RM, Burrows RF. Pregnancy in chronic progressive external ophtalmoplegia: a case report. Am J Perinatol 1997; 14: 293-5.
14. Kovilam OP, Cahill W, Siddiqi TA. Pregnancy with mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome, Obstet Gynecol 1999; 93: 853
15. Kokawa N, Ishii Y, Yamoto M, Nakano R. Pregnancy and delivery complicated by mitochondrial myopathy, encephalopathy, lactic acidosis, and stoke-like episodes. Obstet Gynecol 1998; 91: 865.
16. Yanagawa T, Sakaguchi H, Nakao T, Sasaki H, Matsumoto G, Sanke T, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes with deterioration during pregnancy. Intem Med 1998; 37: 780-3.
17. Soccio PS, Phillips WP, Bonisteel P, Bennett KA. Pregnancy with cytochrome oxidase-deficient mitochondrial myopathy. Obstet Gynecol 2001; 97: 815-6.
18. Rahman S, Blok RB, Dahl HH, Danks DM, Kirby DM, Chow CW, et al. Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol 1996; 39: 343-51.
19. Thorburn DR. Practical problems in detecting abnormal mitochondrial function and genomes. Hum Reprod 2000; 15: 57-67.
20. Thorburn DR, Dahl HH. Mitochondrial disorders: genetics, counselling, prenatal diagnosis and reproductive options. Am J Med Genet 2001; 106: 102-14.
21. White SL, Shanske S, Biros I, Warwick L, Dahl HM, Thorburn DR, et al. Two cases of prenatal analysis for the pathogenic T to G substitution at nucleotide 8993 in mitochondrial DNA. Prenat Diagn 1999; 19: 1165-8.
22. Faivre L, Cormier-Daire V, Chrétien D, Von Kleist-Retzow JC, Amiel J, Dommergues M, et al. Determination of enzyme activities for prenatal diagnosis of respiratory chain deficiency. Prenat Diagn 2000; 20: 732-7.
23. Amiel J, Gigarel N, Benacki A, Benit P, Valnot I, Parfait B, et al. Prenatal diagnosis of respiratory chain deficiency by direct mutation screening. Prenat Diagn 2001; 21: 602-4.
24. Von Kleist-Retzow JC, Cormier-Daire V, De Loulay P, Parfait B, Chrétien D, Rustin P, et al. A high rate (20-30%) of parental consanguinity in cytochrome-oxidase deficiency. Am J Hum Genet 1998; 63: 428-35.
25. Tyni T, Pihko H. Long-chain 3-hydroxyacyl-CoA deshydrogenase deficiency. Acta Paediatr 1999; 88: 237-45.
26. Berkowitz K, Monteagudo A, Marks F, Jackson U, Baxi L. Mitochondrial myopathy and preeclampsia associated with pregnancy. Am J Obstet Gynecol 1990; 162: 146-7.
27. Torbergsen T, Oian P, Mathiesen E, Borud O. Pre-eclampsia-a mitochondrial disease? Acta Obstet Gynecol Scand 1989; 68: 145-8.
28. Folgero T, Storbakk N, Torbergsen T, Oian P. Mutations in mitochondrial transfer ribonucleic acid genes in preeclampsia. Am J Obstet Gynecol 1996; 174: 1626-30.
29. Hosono T, Suzuki M, Chiba Y. Contraindication of magnesium sulfate in a pregnancy complicated with late-onset diabetes mellitus and sensory deafness due to mitochondrial myopathy. J Mareta Fetal Med 2001; 10: 355-6.
30. Van den Ouweland JM, Lemkes HH, Trembath RC, Ross R, Velho G, Cohen D, et al. Maternally inherited diabetes and deafness is a distinct subtype of diabetes and associates with a single point mutation in the mitochondrial tRNA Leu (UUR) gene. Diabetes 1994; 43: 746-51.
31. Kadowaki T, Kadowaki H, Mori Y, Tobe K, Sakuta R, Suzuki Y, et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 1994; 330: 962-8.
32. Ruitenbeek W, Wendel U, Hamel BCJ, Trijbels JMF. Genetic counselling and prenatal diagnosis in disorders of the mitochondrial energy metabolism. J Inher Metab Dis 1996; 19: 581-7.
33. Van Coster RN, Janssens S, Misson JP, Verloes A, Leroy JG. Prenatal diagnosis of pyruvate carboxylase deficiency by direct measurement of catalytic activity on chorionic villi samples. Prenat Diagn 1998; 18: 1041-4.
34. Brown RM, Brown GK. Prenatal diagnosis of pyruvate dehydrogenase E1α subunit deficiency. Prenat Diagn 1994; 14: 435-42.
35. Rouillac C, Aral B, Fouque F, Marchant D, Saudubray JM, Dumez Y, et al. First prenatal diagnosis of defects in the HsPDX1 gene encoding protein X, an additional lipoyl-containing subunit of the human pyruvate dehydrogenase complex. Prenat Diagn 1999; 19: 1160-4.
36. Larsson NG, Eiken HG, Boman H, Holme E, Oldfors A, Tulinius MH. Lack of transmission of deleted mtDNA from a woman with Kearns-Sayre syndrome to her child. Am J Hum Genet 1992; 50: 360-3.
37. Ferlin T, Landrieu P, Rambaud C, Fernandez H, Dumoulin R, Rustin P, et al. Segregation of the G8993 mutant mitochondrial DNA through generation and embryonic tissues in a family at risk of Leigh syndrome. J Pediatr 1997; 131: 447-9.
38. Dahl HH, Thorburn DR, White SL. Towards reliable prenatal diagnosis of mtADN point mutations: studies of nt8993 mutations in oocytes, fetal tissues, children and adults. Hum Reprod 2000; 15: 246-55.
39. Samson JF, Barth PG, de Vries JI, Menko FH, Ruitenbeek W, van Oost BA, et al. Familial mitochondrial encephalopathy with fetal ultrasonographic ventriculomegaly and intracerebral calcifications. Eur J Pediatr 1994; 153: 510-6.
40. Robinson JN, Norwitz ER, Mulkern R, Brown SA, Rybicki F, Tempany CM. Prenatal diagnosis of pyruvate dehydrogenase deficiency using magnetic resonance imaging. Prenat Diagn 2001; 21: 1053-6.
41. Castro-Gago M, Pintos-Martinez E, Forteza-Vila J, Iglesias-Diz M, Ucieda-Somoza R, Silva-Villar I, et al. Congenital hydranencephalic-hydrocephalic syndrome with proliferative vasculopathy: a possible relation with mitochondrial dysfunction. J Child Neurol 2001; 16: 858-62.
42. Rosaeg OP, Morrison S, MacLeod J.P. Anaesthetic management of labour and delivery in the parturient with mitochondrial myopathy. Can J Anaesth 1996; 43: 403-7.
43. Moundras JM, Wattrisse G, Leroy B, Decocq J, Krivosic-Horber R. Prise en charge anesthésique du travail obstétrical chez une parturiente atteinte d'un déficit musculaire en carnitine palmitoyl transférase. Ann Fr Anesth Reanim 2000; 19: 611-6.
44. Remes AM, Liimatta EV, Winqvist S, Tolonen U, Ranua JA, Reinikainen K, et al. Ubiquinone and nicotinamide treatment of patients with the 3243 A-G mtDNA mutation. Neurology 2002; 59: 1275-7.
45. Geromel V, Darin N, Chretien D, Benit P, DeLonlay P, Rötig A, et al. Coenzyme Q (10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits. Mol Genet Metab 2002; 77: 21.
46. Ogle RF, Christodoulou J, Fagan E, Blok RB, Kirby DM, Seller KL, et al. Mitochondrial myopathy with tRNA (Leu (UUR)) mutation and complex I deficiency responsive to riboflavin. J Pediatr 1997; 130: 138-45.
47. Barisic N, Bernert G, Ipsiroglu O, Stromberger C, Muller T, Gruber S, et al. Effects of oral creatine supplementation in a patient with MELAS phenotype and associated nephropathy. Neuropediatrics 2002; 33: 157-61.
48. Oldfors A, Tulinius M. Mitochondrial encephalomyopathies. J Neuropathol Exp Neurol 2003; 62: 217-27.
49. Poulton JR, Marchington D. Progress in genetic counselling and prenatal diagnosis of maternally inherited mtDNA diseases. Neuromuscul Disord 2000; 10: 484-7.
50. Gellerich FN, Deschauer M, Chen Y, Muller T, Neudecker S, Zierz S. Mitochondrial respiratory rates and activities of respiratory chain complexes correlate linearly with heteroplasmy of deleted mtDNA without threshold and independently of deletion size. Biochim Biophys Acta 2002; 1556: 41-52